
  Mrv1572004091615522D          

 12 12  0  0  0  0            999 V2000
   -0.0115    0.3964    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0115   -0.4285    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.6559    0.8813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6789    0.8813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7029   -0.8410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7260   -0.8410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4009    1.6660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4405    0.6264    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4240    1.6660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4173   -0.4285    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7029   -1.6660    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4405   -0.4285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0  0  0  0
  3  1  1  0  0  0  0
  4  1  1  0  0  0  0
  5  2  1  0  0  0  0
  2  6  1  6  0  0  0
  7  3  1  0  0  0  0
  8  3  2  0  0  0  0
  9  4  1  0  0  0  0
 10  5  1  0  0  0  0
 11  5  2  0  0  0  0
 12  6  1  0  0  0  0
  9  7  1  0  0  0  0
M  END
> <DATABASE_ID>
DB01202

> <DATABASE_NAME>
drugbank

> <SMILES>
CC[C@H](N1CCCC1=O)C(N)=O

> <INCHI_IDENTIFIER>
InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1

> <INCHI_KEY>
HPHUVLMMVZITSG-LURJTMIESA-N

> <FORMULA>
C8H14N2O2

> <MOLECULAR_WEIGHT>
170.212

> <EXACT_MASS>
170.105527699

> <JCHEM_ACCEPTOR_COUNT>
2

> <JCHEM_ATOM_COUNT>
26

> <JCHEM_AVERAGE_POLARIZABILITY>
17.794020666665045

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
1

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
0

> <JCHEM_IUPAC>
(2S)-2-(2-oxopyrrolidin-1-yl)butanamide

> <ALOGPS_LOGP>
-0.64

> <JCHEM_LOGP>
-0.5936059006666665

> <ALOGPS_LOGS>
0.24

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
1

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_PKA_STRONGEST_ACIDIC>
16.08866335264141

> <JCHEM_PKA_STRONGEST_BASIC>
-1.5563529151976954

> <JCHEM_POLAR_SURFACE_AREA>
63.4

> <JCHEM_REFRACTIVITY>
44.0793

> <JCHEM_ROTATABLE_BOND_COUNT>
3

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
2.98e+02 g/l

> <JCHEM_TRADITIONAL_IUPAC>
levetiracetam

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB01202

> <SECONDARY_ACCESSION_NUMBERS>
APRD01068

> <DRUG_GROUPS>
approved

> <GENERIC_NAME>
Levetiracetam

> <SYNONYMS>
Levetiracetam; Levetiracetame; Levetiracetamum

> <PRODUCTS>
Abbott-levetiracetam; Ach-levetiracetam; Ag-levetiracetam; Apo-levetiracetam; Auro-levetiracetam; Ava-levetiracetam; Bio-levetiracetam; Dom-levetiracetam; Elepsia XR; Elepsia XR 1000 mg; Elepsia XR 1500 mg; Jamp Levetiracetam Tablets; Jamp-levetiracetam; Keppra; Keppra XR; LEVETIRACETAM Extended-release; LEVETIRACETAM solution; Levertiracetam; Levetiracetam; Levetiracetam 1000 mg; Levetiracetam 250 mg; Levetiracetam 750 mg; Levetiracetam Accord; Levetiracetam Actavis; Levetiracetam Actavis Group; Levetiracetam ER; Levetiracetam Extended Release; Levetiracetam Extended-Release; Levetiracetam Extended-release; Levetiracetam Hospira; Levetiracetam Injection USP; Levetiracetam Levetiracetam; Levetiracetam Micro; Levetiracetam Ratiopharm; Levetiracetam Sun; Levetiracetam Teva; Levetiracetam extended-release; Levetiracetam in Sodium Chloride; Levetiractam; M-levetiracetam; Matever; Mint-levetiracetam; Nat-levetiracetam; Novo-levetiracetam; Nra-levetiracetam; Nu-levetiracetam; PHL-levetiracetam; PMS-levetiracetam; Pdp-levetiracetam; Pharma-levetiracetam; Priva-levetiracetam; Pro-levetiracetam - 250; Pro-levetiracetam - 500; Pro-levetiracetam - 750; Ran-levetiracetam; Riva-levetiracetam; Roweepra; Roweepra XR; Sandoz Levetiracetam; Spritam; Teva-levetiracetam; Torrent-levetiracetam; Van-levetiracetam

$$$$
